These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21439856)

  • 1. CD94 is essential for NK cell-mediated resistance to a lethal viral disease.
    Fang M; Orr MT; Spee P; Egebjerg T; Lanier LL; Sigal LJ
    Immunity; 2011 Apr; 34(4):579-89. PubMed ID: 21439856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral infection modulates Qa-1b in infected and bystander cells to properly direct NK cell killing.
    Ferez M; Knudson CJ; Lev A; Wong EB; Alves-Peixoto P; Tang L; Stotesbury C; Sigal LJ
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33765134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
    Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F
    J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Lymphocytic Choriomeningitis Infection Causes Susceptibility to Mousepox and Impairs Natural Killer Cell Maturation and Function.
    Alves-Peixoto P; Férez M; Knudson CJ; Stotesbury C; Melo-Silva CR; Wong EB; Correia-Neves M; Sigal LJ
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31776282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells.
    Vance RE; Tanamachi DM; Hanke T; Raulet DH
    Eur J Immunol; 1997 Dec; 27(12):3236-41. PubMed ID: 9464811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene.
    Cantoni C; Biassoni R; Pende D; Sivori S; Accame L; Pareti L; Semenzato G; Moretta L; Moretta A; Bottino C
    Eur J Immunol; 1998 Jan; 28(1):327-38. PubMed ID: 9485212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Qa-1b molecule binds to a large subpopulation of murine NK cells.
    Salcedo M; Bousso P; Ljunggren HG; Kourilsky P; Abastado JP
    Eur J Immunol; 1998 Dec; 28(12):4356-61. PubMed ID: 9862372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
    Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
    J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49.
    Toyama-Sorimachi N; Taguchi Y; Yagita H; Kitamura F; Kawasaki A; Koyasu S; Karasuyama H
    J Immunol; 2001 Mar; 166(6):3771-9. PubMed ID: 11238619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.
    Davis ZB; Cogswell A; Scott H; Mertsching A; Boucau J; Wambua D; Le Gall S; Planelles V; Campbell KS; Barker E
    PLoS Pathog; 2016 Feb; 12(2):e1005421. PubMed ID: 26828202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
    Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
    EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells.
    Van Beneden K; Stevenaert F; De Creus A; Debacker V; De Boever J; Plum J; Leclercq G
    J Immunol; 2001 Apr; 166(7):4302-11. PubMed ID: 11254682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells.
    Miller JD; Peters M; Oran AE; Beresford GW; Harrington L; Boss JM; Altman JD
    J Immunol; 2002 Jul; 169(2):693-701. PubMed ID: 12097371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.
    Miller JD; Weber DA; Ibegbu C; Pohl J; Altman JD; Jensen PE
    J Immunol; 2003 Aug; 171(3):1369-75. PubMed ID: 12874227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.
    Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M
    Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants.
    Carretero M; Palmieri G; Llano M; Tullio V; Santoni A; Geraghty DE; López-Botet M
    Eur J Immunol; 1998 Apr; 28(4):1280-91. PubMed ID: 9565368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for NKG2D in NK cell-mediated resistance to poxvirus disease.
    Fang M; Lanier LL; Sigal LJ
    PLoS Pathog; 2008 Feb; 4(2):e30. PubMed ID: 18266471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.
    Pietra G; Romagnani C; Moretta L; Mingari MC
    Curr Pharm Des; 2009; 15(28):3336-44. PubMed ID: 19860683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.